GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Market Cap

SOLTF (Nxera Pharma Co) Market Cap : $511.2 Mil (As of Apr. 04, 2025)


View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nxera Pharma Co's share price for the quarter that ended in Dec. 2024 was $6.1575. Nxera Pharma Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 89.9 Mil. Therefore, Nxera Pharma Co's market cap for the quarter that ended in Dec. 2024 was $553.6 Mil.

Nxera Pharma Co's quarterly market cap declined from Jun. 2024 ($847.8 Mil) to Sep. 2024 ($822.6 Mil) and declined from Sep. 2024 ($822.6 Mil) to Dec. 2024 ($553.6 Mil).

Nxera Pharma Co's annual market cap declined from Dec. 2022 ($930.6 Mil) to Dec. 2023 ($894.5 Mil) and declined from Dec. 2023 ($894.5 Mil) to Dec. 2024 ($553.6 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nxera Pharma Co's Enterprise Value for Today is $732.6 Mil.


Nxera Pharma Co Market Cap Historical Data

The historical data trend for Nxera Pharma Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Market Cap Chart

Nxera Pharma Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,272.61 1,391.51 930.65 894.46 553.57

Nxera Pharma Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 894.46 941.51 847.78 822.59 553.57

Competitive Comparison of Nxera Pharma Co's Market Cap

For the Biotechnology subindustry, Nxera Pharma Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nxera Pharma Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Market Cap falls into.


;
;

Nxera Pharma Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Nxera Pharma Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=$6.1575*89.901
=$553.6

Nxera Pharma Co's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=$6.1575*89.901
=$553.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nxera Pharma Co  (OTCPK:SOLTF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Nxera Pharma Co Market Cap Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Nxera Pharma Co Business Description

Traded in Other Exchanges
Address
Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).